600165 *ST宁科生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)527.242-116.790-20.217-19.2402.250
总资产报酬率 ROA (%)-18.550-14.929-4.298-5.0020.749
投入资产回报率 ROIC (%)-37.413-23.967-6.126-6.6130.774

边际利润分析
销售毛利率 (%)-0.349-34.93011.112-32.9349.223
营业利润率 (%)-261.941-173.002-23.775-74.8612.226
息税前利润/营业总收入 (%)-209.728-131.109-11.173-62.63836.110
净利润/营业总收入 (%)-270.382-180.667-24.974-76.16619.478

收益指标分析
经营活动净收益/利润总额(%)33.75560.97489.96993.760-206.382
价值变动净收益/利润总额(%)49.435-6.619-21.092-21.262208.018
营业外收支净额/利润总额(%)3.0814.2952.2970.45986.789

偿债能力分析
流动比率 (X)0.1610.1100.1610.2890.630
速动比率 (X)0.0890.0570.0910.1550.560
资产负债率 (%)107.00687.08472.73167.82261.827
带息债务/全部投入资本 (%)74.15057.31146.67940.677--
股东权益/带息债务 (%)-54.49917.24961.65677.84488.936
股东权益/负债合计 (%)-14.7726.51826.39034.35846.377
利息保障倍数 (X)-3.464-2.640-0.849-4.9841.875

营运能力分析
应收账款周转天数 (天)70.99256.53713.79547.1130.000
存货周转天数 (天)163.57195.78975.598122.2670.000